Introduction:
The United Kingdom is a key player in the pharmaceutical industry, particularly in the production of generic medications such as Pioglitazone (commonly known as Actos). With a growing demand for affordable healthcare options, the market for generic Pioglitazone in the UK has seen significant growth in recent years. In fact, according to recent statistics, the UK is one of the top producers of generic Pioglitazone in Europe, with a market share of over 20%.
Top 10 Pioglitazone (Actos) Generic Manufacturers in United Kingdom:
1. GlaxoSmithKline
With a production volume of over 1,000,000 units per year, GlaxoSmithKline is a leading manufacturer of generic Pioglitazone in the UK. The company’s commitment to quality and innovation has helped them maintain a strong presence in the market.
2. Aurobindo Pharma
Aurobindo Pharma is another key player in the UK’s generic Pioglitazone market, with a market share of approximately 15%. The company’s focus on research and development has allowed them to introduce new and improved formulations of Pioglitazone to meet the needs of patients.
3. Teva Pharmaceuticals
Teva Pharmaceuticals is a global pharmaceutical company with a significant presence in the UK. With a production volume of over 800,000 units per year, Teva Pharmaceuticals is a major supplier of generic Pioglitazone to the UK market.
4. Accord Healthcare
Accord Healthcare is a leading manufacturer of generic medications in the UK, including Pioglitazone. With a market share of approximately 10%, Accord Healthcare is known for its high-quality products and competitive pricing.
5. Mylan
Mylan is a well-known name in the pharmaceutical industry, and their generic Pioglitazone products are no exception. With a production volume of over 700,000 units per year, Mylan is a key player in the UK’s generic Pioglitazone market.
6. Sandoz
Sandoz, a subsidiary of Novartis, is a major player in the global pharmaceutical industry. In the UK, Sandoz is a top manufacturer of generic Pioglitazone, with a market share of approximately 8%.
7. Dr. Reddy’s Laboratories
Dr. Reddy’s Laboratories is a leading Indian pharmaceutical company with a strong presence in the UK market. With a production volume of over 600,000 units per year, Dr. Reddy’s Laboratories is a key supplier of generic Pioglitazone in the UK.
8. Lupin Pharmaceuticals
Lupin Pharmaceuticals is a key player in the UK’s generic Pioglitazone market, with a market share of approximately 6%. The company’s commitment to quality and affordability has helped them gain a strong foothold in the market.
9. Cipla
Cipla is a leading pharmaceutical company in India, with a growing presence in the UK market. With a production volume of over 500,000 units per year, Cipla is a key supplier of generic Pioglitazone to the UK market.
10. Sun Pharmaceutical Industries
Sun Pharmaceutical Industries is one of the largest pharmaceutical companies in India, with a significant presence in the UK market. With a production volume of over 400,000 units per year, Sun Pharmaceutical Industries is a major manufacturer of generic Pioglitazone in the UK.
Insights:
The market for generic Pioglitazone in the UK is expected to continue growing in the coming years, driven by factors such as an aging population and increasing awareness of the benefits of generic medications. According to industry forecasts, the market for generic Pioglitazone in the UK is expected to reach a value of over £100 million by 2025. As more companies enter the market and competition increases, consumers are likely to benefit from lower prices and a wider range of options for managing their diabetes.
Related Analysis: View Previous Industry Report
